Filter
352
Filtered Results: 352
Text search:
inactivated
vaccines
Featured
Recommendations
44
New Publications
105
Language
Document type
No document type
172
Guidelines
89
Studies & Reports
38
Manuals
20
Fact sheets
19
Strategic & Response Plan
6
Situation Updates
5
Training Material
2
Resource Platforms
1
Countries / Regions
Germany
11
India
11
Global
10
South Africa
10
Nigeria
8
Latin America and the Carribbean
7
Pakistan
7
Sierra Leone
6
Syria
6
Philippines
6
Ethiopia
6
Nepal
5
Afghanistan
5
Tanzania
5
Kenya
4
Ukraine
4
Chile
4
Uganda
4
Namibia
4
Africa
3
Middle East and North Africa
3
Western and Central Europe
3
Russia
3
Yemen
3
Ecuador
3
Myanmar / Burma
3
Rwanda
2
Venezuela
2
Congo, Democratic Republic of
2
West and Central Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
East and Southern Africa
2
Bangladesh
2
Papua New Guinea
2
Zambia
2
Liberia
2
North Macedonia
1
Colombia
1
Lesotho
1
Turkey
1
Gambia
1
China
1
Niger
1
Peru
1
Malawi
1
Zimbabwe
1
Jordan
1
Paraguay
1
Bolivia
1
Argentina
1
Lebanon
1
Brazil
1
Egypt
1
Libya
1
Bhutan
1
Botswana
1
Indonesia
1
Iraq
1
Somalia
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Guidelines
30
COVID-19
21
Drugs & Medical Equipment
17
Vaccine-preventable Diseases
15
Studies & Reports
13
Policies
11
Statistics
10
Immunization
9
Countries
7
Policies & Guidelines HIV & TB
7
General Guidelines
6
Hepatitis
5
Rabies
5
Humanitarian Crisis
5
Disease Prevention & Control
5
Infection Control & Prevention (IPC)
4
Women & Child Health
4
Information, Education and Communication (IEC)
4
General Guidelines
4
Yellow Fever
3
Demograhic Health Surveys DHS
3
WASH
3
Maternal Health
3
HIV & STI
3
Communicable Diseases
2
Paediatrics
2
Child Health
2
Dermatology
2
Diarrhoeal Disease/Cholera
2
Capacity Building
2
Other
2
Respiratory Infections
2
Surgery & Anaesthesia
2
Communicable Diseases
2
NTDs & Others
2
Dengue
2
Pharmacy & Technology
1
Hand Hygiene
1
Humanitarian Aid
1
Cervical Cancer
1
MPOX - Monkeypox
1
Virology
1
Pediatrics
1
NCD
1
Hemorrhagic Fever
1
Community Health
1
Needs Assessment
1
Gynaecology & Obstetrics
1
Laboratory Quality Assurance
1
Water
1
Neonatal Care
1
Reproductive Health
1
Toolboxes
Action Plans, Policies & Response
17
Inactivated COVID-19 Vaccines
13
Immunization Guidelines
11
Communication Material
9
Country specific documents
7
Access & Strategy
7
Booster Doses
7
Vaccination
6
Infection Control General
6
Biontech/Pfizer Comirnaty
6
Essential Medicines & Devices Lists
6
Health Care Systems
6
Outbreak Prevention & Control
5
Laboratory Guidance
5
Vaccination
5
Blood Supply
5
Disease Prevention & Control
5
Context & Facts
5
Situation Reports & Updates
5
IPC
4
Social Worker
4
Public Health
4
Prevention & Preparedness
4
For General Public & Community
4
For Health Worker
4
Physical Distancing
4
Fair Allocation & Ethical Aspects
4
Covaxin
4
Guidelines & Manuals
4
Clinical Aspects & Diagnostics
4
Miscellaneous
4
Infection Control
4
Volunteers
4
Vaccination
4
Treatment Guidelines
3
Agriculture & Veterinary
3
Vaccines & Immunization
3
Children & Adolescents
3
Laboratory & Sampling
3
Scientific & Research Studies
3
Educational Settings
3
Workplace
3
Moderna
3
Rational use of Medicine
3
Studies & Reports
3
Preparedness & Prevention
3
Gynaecology / Obstetrics
2
Assessment & Studies
2
Ebola Prevention & Control
2
Surveillance
2
Yellow Fever
2
Clinical Aspects
2
Clinical Guidelines
2
Key Resources
2
Influenza Prevention & Control
2
Cholera Prevention & Control
2
Health & Refugee
2
Medical professionals
2
Infection Prevention & Hygiene
2
Clinical Aspects
2
COVID-19 Information
2
For Pregnant Women
2
Clinical Guidelines
2
SARS-CoV-2 Variants
2
Vaxzevria (Astra Zeneca)
2
Johnson & Johnson
2
Research & Pipeline
2
Essential Medicines
2
Supply Chain & Store Management
2
General documents One Health
2
General
2
MPOX - Monkeypox
2
MPOX - Monkeypox
2
Clinical Guidelines
2
Assessment & Response
2
Nutrition
2
Reports & Studies Children HIV
2
Context & Facts
2
War & Conflict
1
Public Health
1
Rapid Response
1
Biosafety
1
ART Drug Resistance
1
Male Circumcision
1
Surveillance
1
Clinical Aspects, Treatment & Prevention
1
Europe
1
Treatment & Prevention
1
Yellow Fever Prevention & Control
1
Country specific
1
Prevention & Control
1
Surgery & Rehabilitation
1
Pediatrics
1
Opportunistic Infections
1
WASH
1
Assessment & Response
1
Context, Facts & Travel Advice
1
Dengue
1
Infection Control
1
Hepatitis
1
Namibia
1
HIV
1
Children/Adolescents Mental Disorders
1
Research
1
Ebola
1
Public Health
1
Cholera
1
Workplace
1
General
1
Climate & Health
1
Laboratory
1
Context & Facts
1
Clinical Guidelines
1
Studies
1
Context & Facts, Travel Advice
1
Hand Hygiene
1
Poster & Infographics
1
Risk Communication & Community Engagement
1
Diagnostics & Laboratory Guidance
1
Surveillance & Contact tracing
1
Covid-19 & the One Health Approach
1
Covid-19 & Climate Change
1
For Parents & Children
1
Training, others
1
Country Specific
1
Prison & Detention
1
Medical & Community Masks
1
Hospital Readiness/Essential Health Services
1
COVID-19 Vaccination
1
Non-pharmaceutical interventions (NPIs)
1
Preparedness, Response & Risk Communication
1
Logistics & Supply
1
Genomic sequencing
1
COVAX Initiative
1
Chile
1
Prices and Patents
1
Model Formulary
1
Pharmacy Practice
1
General Guidelines for Rational Use
1
Pharmacovigilance
1
Waste Managment
1
Situation Reports & Updates
1
Zoonoses
1
Infectious Diseases
1
Health Impact & Climate Change
1
Humanitarian Aid Guidelines
1
MPOX -Monkeybox Prevention & Control
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Information & Education Material (IEC)
1
General Information & Methodology
1
Women
1
Co-Morbidities (except TB)
1
Neurological Disorders
1
Autism
1
Situation Reports & Updates
1
Technical Information
1
Malawi
1
TB & Prisoners
1
Education of students & professionals
1
Training
1
Assessment & Response
1
Research & Access
1
Dengue Prevention & Control
1
Technical Information
1
Clinical Guidelines
1
HIV / AIDS
1
Testing Guidelines
1
TB/HIV Coinfection
1
Chikungunya Prevention & Control
1
Zika Prevention & Control
1
WASH
1
WASH
1
Laboratory
1
Psychosocial Support
1
Paediatrics
1
Key Resources
1
Preparedness & Prevention
1
Global Health Financing
1
Laboratory & Diagnostics
1
Kenya
1
Pregnant women
1
Meningitis & Encephalitis
1
Public Health
1
Review Article:
The American Journal of the Medical Sciences 2011;341(6):493–498.]
WHO Secretariat Information paper July 2016
The Global Vaccine Action Plan (GVAP) 2011-2020, endorsed by Member States during the May 2012 World Health Assembly, has set ambitious targets to improve access to immunization and tackle vaccine-preventable diseases. This responsibility has been translated into firm commitments in February 2016, t...
Will COVID-19 vaccines be safe? Will all the COVID-19 candidate vaccines be successful? What are the different phases a vaccine must go through to be approved? This document provides responses to the most frequently asked questions about candidate vaccines and access to COVID-19 vaccination.
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
The purpose of this field guide is to provide comprehensive information on planning and implementing high-quality3 SIAs for injectable vaccines and highlight the opportunities to strengthen RI and surveillance. The guide uses measles–rubella SIAs as the main example throughout, but the informatio...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
The Guidance on National Deployment and Vaccination Planning is intended to help countries develop their plan for COVID-19 vaccine introduction.
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guidance document outlines an approach to leverage existing surveillance systems for Severe Acute Respirato...
This quick guide offers basic information about COVID-19, the Sinovac-CoronaVac COVID-19 vaccine and what to
expect following vaccination: ...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
an approach to optimize the global impact of COVID-19 vaccines, based on public health goals, global and national equity, and vaccine access and coverage scenarios, first issued 20 October 2020, updated: 13 November 2020, updated: 16 July 2021, latest update: 21 January 2022
Available in English, F...
This is an e-learning module with the objective of providing education for health professionals and pregnant women using published results and studies based on COVID-19 surveillance data, which have indicated an increased risk among pregnant women of presenting with severe forms of COVID-19 and, the...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr...
